Upcoming event

Tags

Show all

A 25-year period analysis of other-cause mortality in localized prostate cancer

Clinical Genitourinary Cancer, July 2019

Performance of combined magnetic resonance imaging/ultrasound fusion-guided and systematic biopsy of the prostate in biopsy-naïve patients and patients with prior biopsies

European Urology Focus, July 2019

MRI-targeted or standard biopsy for prostate-cancer diagnosis

The new england journal of medicine 2018 May 10, Volume 378, Issue 19, Pages 1767-1777

Prostate-specific membrane antigen heterogeneity and DNA repair defects in prostate cancer

European Urology, July 2019

Robust health utility assessment among long-term survivors of prostate cancer: Results from the cancer of the prostate strategic urologic research endeavor registry

European Urology, July 2019

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

The Lancet Journal, June 2019

Detection and localisation of primary prostate cancer using 68 Ga-PSMA PET/CT compared with mpMRI and radical prostatectomy specimens

BJU Int., July 2019

Wnt-pathway activating mutations are associated with resistance to first-line abiraterone and enzalutamide in castration-resistant prostate cancer

European Urology, June 2019

Sequencing of taxanes and new androgen-targeted therapies in metastatic castration-resistant prostate cancer: results of the international multicentre retrospective CATS database

European Urology Oncology, Volume 1, Issue 6, December 2018, Pages 467-475

Risk of metastatic disease on 68Ga‐PSMA PET/CT scan for primary staging of 1253 men at the diagnosis of prostate cancer

BJU International, May 2019

Head-to-head comparison of TRUS prostate biopsy vs multiparametric prostate resonance imaging with subsequent MR-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: A large prospective multicenter clinical study

European Urology

Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study

The LANCET Oncology 2018 Nov 20, Volume 20, Issue 1, Pages 100-109

Next